Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

NORMAN BETTLE

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1033180039
CMS profile
183433
Location
BEAUFORT, SC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2019 · Entire year

$12,879.94

103 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2019 · entire year · sorted by reported total

By paying entity

PY2019 · entire year · sorted by reported total

Page 3 of 3; records 101–103 of 103 matching records. This page contains 3 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

NORMAN BETTLE

NPI 1033180039 · CMS profile ID 183433

Allopathic & Osteopathic Physicians / Psychiatry & Neurology / Neurology

BEAUFORT, SC

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 3 of 3; records 101–103 of 103 matching records. This page contains 3 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1033180039?year=2019&recipient=provider&page=3#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
NORMAN BETTLE, NPI 1033180039, CMS profile ID 183433. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–103 of 103 matching records. This page contains 3 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1033180039?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
APA 7
IndustryPayments. (2026). NORMAN BETTLE, NPI 1033180039, CMS profile ID 183433. General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 3 of 3; records 101–103 of 103 matching records. This page contains 3 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1033180039?year=2019&recipient=provider&page=3#records-h. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e.
Bluebook
NORMAN BETTLE, NPI 1033180039, CMS profile ID 183433, IndustryPayments, General Payments, PY2019; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 3 of 3; records 101–103 of 103 matching records. This page contains 3 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/4e54dd6c-30f8-4f86-86a7-3c109a89528e. https://industrypayments.org/provider/npi-1033180039?year=2019&recipient=provider&page=3#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2019

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2019 · Physicians and non-physician practitioners · CMS publication 2026-06-30

103 matching records · $12,879.94 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 103 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 101–103 of 103.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
LivaNova USA, Inc. $20.0101/10/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 703462707 CMS
Allergan Inc. $6.1501/08/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 670117303 CMS
Teva Pharmaceuticals USA, Inc. $16.6801/04/2019 Food and Beverage No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 697835611 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $12,879.94 103
PY2020 $13,244.49 50
PY2021 $14,783.41 54
PY2022 $7,264.26 116
PY2023 $4,977.75 85
PY2024 $8,490.30 108
PY2025 $6,891.55 70

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2020, 2021, 2022, 2023, 2024, 2025
Source files and profile matching
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2023 Principal investigator $21,142.50 246
PY2022 Principal investigator $1,565.04 1

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

246 records in PY2023

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 MDD US Operations, LLC $2.81 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052920861
Principal investigator 1 MDD US Operations, LLC $23.44 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052920867
Principal investigator 1 MDD US Operations, LLC $18.75 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052920873
Principal investigator 1 MDD US Operations, LLC $6.56 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052920879
Principal investigator 1 MDD US Operations, LLC $6.56 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052920885
Principal investigator 1 MDD US Operations, LLC $42.19 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052920891
Principal investigator 1 MDD US Operations, LLC $2.81 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052920897
Principal investigator 1 MDD US Operations, LLC $4.69 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052920903
Principal investigator 1 MDD US Operations, LLC $6.56 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052920915
Principal investigator 1 MDD US Operations, LLC $9.38 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052920921
Principal investigator 1 MDD US Operations, LLC $9.38 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052920927
Principal investigator 1 MDD US Operations, LLC $18.75 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052920935
Principal investigator 1 MDD US Operations, LLC $4.69 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052920941
Principal investigator 1 MDD US Operations, LLC $6.56 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052920947
Principal investigator 1 MDD US Operations, LLC $9.38 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052920953
Principal investigator 1 MDD US Operations, LLC $4.69 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052920959
Principal investigator 1 MDD US Operations, LLC $5.62 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052920965
Principal investigator 1 MDD US Operations, LLC $2.81 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052920971
Principal investigator 1 MDD US Operations, LLC $6.56 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052920983
Principal investigator 1 MDD US Operations, LLC $18.75 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052920989
Principal investigator 1 MDD US Operations, LLC $5.62 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052920995
Principal investigator 1 MDD US Operations, LLC $3.94 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921001
Principal investigator 1 MDD US Operations, LLC $2.81 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921007
Principal investigator 1 MDD US Operations, LLC $18.75 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921015
Principal investigator 1 MDD US Operations, LLC $3.94 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921021
Principal investigator 1 MDD US Operations, LLC $9.38 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921027
Principal investigator 1 MDD US Operations, LLC $42.19 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921033
Principal investigator 1 MDD US Operations, LLC $2.81 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921039
Principal investigator 1 MDD US Operations, LLC $23.44 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921051
Principal investigator 1 MDD US Operations, LLC $24.00 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921057
Principal investigator 1 MDD US Operations, LLC $2.81 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921063
Principal investigator 1 MDD US Operations, LLC $9.38 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921069
Principal investigator 1 MDD US Operations, LLC $4.69 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921077
Principal investigator 1 MDD US Operations, LLC $28.12 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921083
Principal investigator 1 MDD US Operations, LLC $2.81 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921089
Principal investigator 1 MDD US Operations, LLC $42.19 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921095
Principal investigator 1 MDD US Operations, LLC $4.69 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921101
Principal investigator 1 MDD US Operations, LLC $4.69 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921107
Principal investigator 1 MDD US Operations, LLC $6.56 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921119
Principal investigator 1 MDD US Operations, LLC $3.94 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921125
Principal investigator 1 MDD US Operations, LLC $5.62 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921131
Principal investigator 1 MDD US Operations, LLC $2.81 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921137
Principal investigator 1 MDD US Operations, LLC $11.25 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921143
Principal investigator 1 MDD US Operations, LLC $4.69 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921151
Principal investigator 1 MDD US Operations, LLC $6.56 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921159
Principal investigator 1 MDD US Operations, LLC $4.69 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921165
Principal investigator 1 MDD US Operations, LLC $2.81 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921171
Principal investigator 1 MDD US Operations, LLC $4.69 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921177
Principal investigator 1 MDD US Operations, LLC $2.81 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921189
Principal investigator 1 MDD US Operations, LLC $23.44 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921195
Principal investigator 1 MDD US Operations, LLC $18.75 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921201
Principal investigator 1 MDD US Operations, LLC $18.75 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921207
Principal investigator 1 MDD US Operations, LLC $18.75 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921213
Principal investigator 1 MDD US Operations, LLC $18.75 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921219
Principal investigator 1 MDD US Operations, LLC $6.56 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921225
Principal investigator 1 MDD US Operations, LLC $18.75 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921231
Principal investigator 1 MDD US Operations, LLC $28.12 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921237
Principal investigator 1 MDD US Operations, LLC $2.81 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921243
Principal investigator 1 MDD US Operations, LLC $24.00 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921255
Principal investigator 1 MDD US Operations, LLC $18.75 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921261
Principal investigator 1 MDD US Operations, LLC $9.38 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921267
Principal investigator 1 MDD US Operations, LLC $18.75 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921273
Principal investigator 1 MDD US Operations, LLC $18.75 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921279
Principal investigator 1 MDD US Operations, LLC $18.75 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921285
Principal investigator 1 MDD US Operations, LLC $2.81 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921291
Principal investigator 1 MDD US Operations, LLC $18.75 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921299
Principal investigator 1 MDD US Operations, LLC $6.56 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921305
Principal investigator 1 MDD US Operations, LLC $9.38 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921317
Principal investigator 1 MDD US Operations, LLC $4.69 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921323
Principal investigator 1 MDD US Operations, LLC $5.62 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921329
Principal investigator 1 MDD US Operations, LLC $42.19 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921335
Principal investigator 1 MDD US Operations, LLC $3.94 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921343
Principal investigator 1 MDD US Operations, LLC $5.62 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921355
Principal investigator 1 MDD US Operations, LLC $6.56 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921361
Principal investigator 1 MDD US Operations, LLC $2.81 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921367
Principal investigator 1 MDD US Operations, LLC $2.81 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921373
Principal investigator 1 MDD US Operations, LLC $23.44 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921379
Principal investigator 1 MDD US Operations, LLC $75.00 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921391
Principal investigator 1 MDD US Operations, LLC $6.56 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921397
Principal investigator 1 MDD US Operations, LLC $2.81 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921401
Principal investigator 1 MDD US Operations, LLC $2.81 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921407
Principal investigator 1 MDD US Operations, LLC $2.81 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921413
Principal investigator 1 MDD US Operations, LLC $4.69 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921419
Principal investigator 1 MDD US Operations, LLC $23.44 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921425
Principal investigator 1 MDD US Operations, LLC $3.94 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921431
Principal investigator 1 MDD US Operations, LLC $42.19 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921437
Principal investigator 1 MDD US Operations, LLC $4.69 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921443
Principal investigator 1 MDD US Operations, LLC $24.00 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921455
Principal investigator 1 MDD US Operations, LLC $3.94 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921461
Principal investigator 1 MDD US Operations, LLC $5.62 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921467
Principal investigator 1 MDD US Operations, LLC $2.81 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921473
Principal investigator 1 MDD US Operations, LLC $42.19 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921479
Principal investigator 1 MDD US Operations, LLC $4.69 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921485
Principal investigator 1 MDD US Operations, LLC $6.56 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921491
Principal investigator 1 MDD US Operations, LLC $6.56 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921497
Principal investigator 1 MDD US Operations, LLC $42.19 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921503
Principal investigator 1 MDD US Operations, LLC $23.44 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921509
Principal investigator 1 MDD US Operations, LLC $75.00 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921523
Principal investigator 1 MDD US Operations, LLC $28.12 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921531
Principal investigator 1 MDD US Operations, LLC $14.06 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921537
Principal investigator 1 MDD US Operations, LLC $9.38 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921543
Principal investigator 1 MDD US Operations, LLC $6.56 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921549
Principal investigator 1 MDD US Operations, LLC $5.62 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921555
Principal investigator 1 MDD US Operations, LLC $4.69 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921561
Principal investigator 1 MDD US Operations, LLC $9.38 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921567
Principal investigator 1 MDD US Operations, LLC $2.81 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921573
Principal investigator 1 MDD US Operations, LLC $28.12 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921579
Principal investigator 1 MDD US Operations, LLC $6.56 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921591
Principal investigator 1 MDD US Operations, LLC $24.00 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921597
Principal investigator 1 MDD US Operations, LLC $9.38 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921603
Principal investigator 1 MDD US Operations, LLC $4.69 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921609
Principal investigator 1 MDD US Operations, LLC $4.69 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921615
Principal investigator 1 MDD US Operations, LLC $3.94 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921621
Principal investigator 1 MDD US Operations, LLC $6.56 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921627
Principal investigator 1 MDD US Operations, LLC $6.56 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921633
Principal investigator 1 MDD US Operations, LLC $2.81 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921637
Principal investigator 1 MDD US Operations, LLC $6.56 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921643
Principal investigator 1 MDD US Operations, LLC $9.38 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921655
Principal investigator 1 MDD US Operations, LLC $6.56 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921661
Principal investigator 1 MDD US Operations, LLC $6.56 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921667
Principal investigator 1 MDD US Operations, LLC $6.56 08/15/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052921673
Principal investigator 1 MDD US Operations, LLC $15.94 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915535
Principal investigator 1 MDD US Operations, LLC $132.81 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915546
Principal investigator 1 MDD US Operations, LLC $106.25 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915557
Principal investigator 1 MDD US Operations, LLC $37.19 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915567
Principal investigator 1 MDD US Operations, LLC $37.19 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915587
Principal investigator 1 MDD US Operations, LLC $239.06 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915597
Principal investigator 1 MDD US Operations, LLC $15.94 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915607
Principal investigator 1 MDD US Operations, LLC $26.56 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915617
Principal investigator 1 MDD US Operations, LLC $37.19 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915625
Principal investigator 1 MDD US Operations, LLC $53.12 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915635
Principal investigator 1 MDD US Operations, LLC $53.12 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915647
Principal investigator 1 MDD US Operations, LLC $106.25 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915657
Principal investigator 1 MDD US Operations, LLC $26.56 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915667
Principal investigator 1 MDD US Operations, LLC $37.19 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915677
Principal investigator 1 MDD US Operations, LLC $53.12 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915699
Principal investigator 1 MDD US Operations, LLC $26.56 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915709
Principal investigator 1 MDD US Operations, LLC $31.88 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915719
Principal investigator 1 MDD US Operations, LLC $15.94 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915731
Principal investigator 1 MDD US Operations, LLC $37.19 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915741
Principal investigator 1 MDD US Operations, LLC $106.25 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915751
Principal investigator 1 MDD US Operations, LLC $31.88 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915761
Principal investigator 1 MDD US Operations, LLC $22.31 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915773
Principal investigator 1 MDD US Operations, LLC $15.94 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915783
Principal investigator 1 MDD US Operations, LLC $106.25 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915793
Principal investigator 1 MDD US Operations, LLC $22.31 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915825
Principal investigator 1 MDD US Operations, LLC $53.12 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915835
Principal investigator 1 MDD US Operations, LLC $4,500.00 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915846
Principal investigator 1 MDD US Operations, LLC $239.06 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915857
Principal investigator 1 MDD US Operations, LLC $15.94 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915867
Principal investigator 1 MDD US Operations, LLC $132.81 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915873
Principal investigator 1 MDD US Operations, LLC $136.00 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915879
Principal investigator 1 MDD US Operations, LLC $15.94 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915885
Principal investigator 1 MDD US Operations, LLC $53.12 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915891
Principal investigator 1 MDD US Operations, LLC $26.56 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915897
Principal investigator 1 MDD US Operations, LLC $159.38 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915909
Principal investigator 1 MDD US Operations, LLC $15.94 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915915
Principal investigator 1 MDD US Operations, LLC $239.06 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915921
Principal investigator 1 MDD US Operations, LLC $26.56 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915927
Principal investigator 1 MDD US Operations, LLC $26.56 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915933
Principal investigator 1 MDD US Operations, LLC $37.19 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915939
Principal investigator 1 MDD US Operations, LLC $22.31 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915945
Principal investigator 1 MDD US Operations, LLC $31.88 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915951
Principal investigator 1 MDD US Operations, LLC $15.94 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915957
Principal investigator 1 MDD US Operations, LLC $63.75 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915965
Principal investigator 1 MDD US Operations, LLC $26.56 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915975
Principal investigator 1 MDD US Operations, LLC $37.19 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915981
Principal investigator 1 MDD US Operations, LLC $26.56 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915987
Principal investigator 1 MDD US Operations, LLC $15.94 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915993
Principal investigator 1 MDD US Operations, LLC $26.56 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052915999
Principal investigator 1 MDD US Operations, LLC $15.94 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916005
Principal investigator 1 MDD US Operations, LLC $132.81 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916011
Principal investigator 1 MDD US Operations, LLC $106.25 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916015
Principal investigator 1 MDD US Operations, LLC $106.25 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916021
Principal investigator 1 MDD US Operations, LLC $106.25 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916025
Principal investigator 1 MDD US Operations, LLC $106.25 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916037
Principal investigator 1 MDD US Operations, LLC $37.19 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916043
Principal investigator 1 MDD US Operations, LLC $106.25 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916047
Principal investigator 1 MDD US Operations, LLC $159.38 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916053
Principal investigator 1 MDD US Operations, LLC $15.94 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916058
Principal investigator 1 MDD US Operations, LLC $136.00 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916063
Principal investigator 1 MDD US Operations, LLC $106.25 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916069
Principal investigator 1 MDD US Operations, LLC $53.12 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916075
Principal investigator 1 MDD US Operations, LLC $106.25 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916081
Principal investigator 1 MDD US Operations, LLC $106.25 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916087
Principal investigator 1 MDD US Operations, LLC $106.25 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916099
Principal investigator 1 MDD US Operations, LLC $15.94 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916105
Principal investigator 1 MDD US Operations, LLC $106.25 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916111
Principal investigator 1 MDD US Operations, LLC $1,000.00 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916117
Principal investigator 1 MDD US Operations, LLC $37.19 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916123
Principal investigator 1 MDD US Operations, LLC $53.12 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916129
Principal investigator 1 MDD US Operations, LLC $26.56 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916135
Principal investigator 1 MDD US Operations, LLC $31.88 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916139
Principal investigator 1 MDD US Operations, LLC $239.06 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916145
Principal investigator 1 MDD US Operations, LLC $22.31 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916151
Principal investigator 1 MDD US Operations, LLC $31.88 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916157
Principal investigator 1 MDD US Operations, LLC $37.19 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916169
Principal investigator 1 MDD US Operations, LLC $15.94 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916175
Principal investigator 1 MDD US Operations, LLC $15.94 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916181
Principal investigator 1 MDD US Operations, LLC $132.81 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916187
Principal investigator 1 MDD US Operations, LLC $425.00 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916193
Principal investigator 1 MDD US Operations, LLC $37.19 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916199
Principal investigator 1 MDD US Operations, LLC $15.94 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916205
Principal investigator 1 MDD US Operations, LLC $15.94 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916211
Principal investigator 1 MDD US Operations, LLC $15.94 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916217
Principal investigator 1 MDD US Operations, LLC $26.56 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916223
Principal investigator 1 MDD US Operations, LLC $132.81 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916235
Principal investigator 1 MDD US Operations, LLC $22.31 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916241
Principal investigator 1 MDD US Operations, LLC $239.06 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916247
Principal investigator 1 MDD US Operations, LLC $26.56 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916253
Principal investigator 1 MDD US Operations, LLC $136.00 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916259
Principal investigator 1 MDD US Operations, LLC $22.31 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916265
Principal investigator 1 MDD US Operations, LLC $31.88 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916273
Principal investigator 1 MDD US Operations, LLC $15.94 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916277
Principal investigator 1 MDD US Operations, LLC $239.06 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916283
Principal investigator 1 MDD US Operations, LLC $26.56 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916289
Principal investigator 1 MDD US Operations, LLC $37.19 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916301
Principal investigator 1 MDD US Operations, LLC $37.19 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916307
Principal investigator 1 MDD US Operations, LLC $239.06 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916313
Principal investigator 1 MDD US Operations, LLC $132.81 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916321
Principal investigator 1 MDD US Operations, LLC $425.00 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916327
Principal investigator 1 MDD US Operations, LLC $159.38 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916333
Principal investigator 1 MDD US Operations, LLC $79.69 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916339
Principal investigator 1 MDD US Operations, LLC $53.12 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916347
Principal investigator 1 MDD US Operations, LLC $37.19 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916351
Principal investigator 1 MDD US Operations, LLC $31.88 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916357
Principal investigator 1 MDD US Operations, LLC $26.56 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916369
Principal investigator 1 MDD US Operations, LLC $53.12 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916375
Principal investigator 1 MDD US Operations, LLC $15.94 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916381
Principal investigator 1 MDD US Operations, LLC $159.38 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916389
Principal investigator 1 MDD US Operations, LLC $37.19 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916393
Principal investigator 1 MDD US Operations, LLC $136.00 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916399
Principal investigator 1 MDD US Operations, LLC $53.12 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916405
Principal investigator 1 MDD US Operations, LLC $26.56 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916411
Principal investigator 1 MDD US Operations, LLC $26.56 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916417
Principal investigator 1 MDD US Operations, LLC $22.31 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916423
Principal investigator 1 MDD US Operations, LLC $37.19 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916435
Principal investigator 1 MDD US Operations, LLC $37.19 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916441
Principal investigator 1 MDD US Operations, LLC $15.94 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916447
Principal investigator 1 MDD US Operations, LLC $37.19 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916453
Principal investigator 1 MDD US Operations, LLC $53.12 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916459
Principal investigator 1 MDD US Operations, LLC $37.19 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916465
Principal investigator 1 MDD US Operations, LLC $37.19 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916471
Principal investigator 1 MDD US Operations, LLC $37.19 06/27/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT UPPER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052916477
Principal investigator 1 MDD US Operations, LLC $4,500.00 06/06/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT LOWER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052882109
Principal investigator 1 MDD US Operations, LLC $1,000.00 06/06/2023 Non-covered Recipient Entity
COASTAL NEUROLOGY PA
A PHASE 2/3, MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, SINGLE-TREATMENT EFFICACY AND SAFETY STUDY OF MYOBLOC IN THE TREATMENT OF ADULT LOWER LIMB SPASTICITY FOLLOWED BY AN OPEN-LABEL EXTENSION, MULTIPLE-TREATMENT SAFETY STUDY OF MYOBLOC No dispute reported 06/30/2026 1052882121